Access Bio invests 7.8 billion KRW in facilities to expand COVID-19 diagnostic kit production

[Asia Economy Reporter Geum Bo-ryeong] Access Bio announced on the 20th that it will invest 7.8 billion KRW in purchasing automated production equipment to expand the production capacity of its COVID-19 diagnostic kits.

The investment amount is 27.79% of the consolidated equity as of last year. The investment period is until May 19, 2021.